Reguclin Consulting

Founded in 2023 and headquartered in the Netherlands, Reguclin Consulting is a boutique consulting firm offering end-to-end clinical development strategy, regulatory affairs support, and medical writing services tailored for pharmaceutical and biotech companies worldwide. Our solutions include New Medicinal Product Identification, Clinical Development, KOL Engagement & Management, Medical Affairs, Medical Writing, Clinical/Nonclinical Due Diligence & Scientific Advice, Pharmacovigilance, Regulatory Affairs, GCP & GVP trainings and audit readiness. We partner with our clients to help them: - Accelerate development timelines - Navigate regulatory complexity with confidence - Craft compelling clinical and regulatory narratives - Maximize the value of their scientific assets We help our clients make critical “go/no-go” decisions by mapping the clinical, regulatory, and commercial viability of new therapeutic concepts. Our expertise spans small molecules, biologics, biosimilars, vaccines, differentiated products and complex generics across multiple therapeutic areas. At Reguclin, we are continually evolving—exploring new partnerships and building capabilities to support next-generation therapeutics, including: - Cell and gene therapies - Digital therapeutics - Drug-device combinations - Repurposed molecules - AI-enabled clinical tools Whether you're a startup looking to design your first clinical program or an established company seeking senior-level strategic clinico-regulatory support, Reguclin Consulting is your trusted partner in bringing innovation to market.